F Gaillard

472 total citations
26 papers, 402 citations indexed

About

F Gaillard is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, F Gaillard has authored 26 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in F Gaillard's work include Computational Drug Discovery Methods (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). F Gaillard is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). F Gaillard collaborates with scholars based in France and United States. F Gaillard's co-authors include Michel Dautrevaux, Gilles Favre, G Soula, André Racadot, Kia‐Ki Han, Françoise Nepveu, Anne Pradines, Jean‐Pierre Souchard, M Dautrevaux and M.H. Loucheux-Lefebvre and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

F Gaillard

26 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Gaillard France 11 163 105 98 77 42 26 402
Munawar Iqbal United Kingdom 13 144 0.9× 67 0.6× 78 0.8× 182 2.4× 21 0.5× 28 590
Victoria R. Cook United States 12 221 1.4× 81 0.8× 199 2.0× 196 2.5× 35 0.8× 14 518
Claude Hoinard France 12 169 1.0× 92 0.9× 33 0.3× 25 0.3× 57 1.4× 20 362
Olga Terebus-Kekish United States 11 164 1.0× 102 1.0× 86 0.9× 90 1.2× 41 1.0× 21 358
Josh P. Kupferberg United States 8 264 1.6× 35 0.3× 120 1.2× 77 1.0× 37 0.9× 11 415
H. P. Morris United States 13 328 2.0× 204 1.9× 55 0.6× 49 0.6× 106 2.5× 29 596
Joaquim Puigjaner Spain 10 488 3.0× 298 2.8× 57 0.6× 39 0.5× 79 1.9× 14 725
Norbert I. Swislocki United States 15 328 2.0× 27 0.3× 99 1.0× 68 0.9× 182 4.3× 44 625
Osamu Asano Japan 12 215 1.3× 35 0.3× 86 0.9× 99 1.3× 55 1.3× 36 652
Pitot Hc United States 7 241 1.5× 81 0.8× 56 0.6× 26 0.3× 35 0.8× 13 412

Countries citing papers authored by F Gaillard

Since Specialization
Citations

This map shows the geographic impact of F Gaillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Gaillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Gaillard more than expected).

Fields of papers citing papers by F Gaillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Gaillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Gaillard. The network helps show where F Gaillard may publish in the future.

Co-authorship network of co-authors of F Gaillard

This figure shows the co-authorship network connecting the top 25 collaborators of F Gaillard. A scholar is included among the top collaborators of F Gaillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Gaillard. F Gaillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pradines, Anne, et al.. (1999). Epidermal Growth Factor Stimulates 3-Hydroxy-3-Methylglutaryl-coenzyme A Reductase Expression via the ErbB-2 Pathway in Human Breast Adenocarcinoma Cells. Biochemical and Biophysical Research Communications. 260(3). 699–706. 28 indexed citations
2.
Pradines, Anne, et al.. (1998). Tyrosine kinase-dependent modulation of 3-hydroxy-3-methylglutaryl-CoA reductase in human breast adenocarcinoma SKBR-3 cells. Biochemical Journal. 330(1). 241–246. 10 indexed citations
3.
Souchard, Jean‐Pierre, et al.. (1996). Indium-111 Labeling of Low Density Lipoproteins with the DTPA−Bis(stearylamide):  Evaluation as a Potential Radiopharmaceutical for Tumor Localization. Bioconjugate Chemistry. 7(1). 72–81. 39 indexed citations
5.
Mauriac, L., et al.. (1995). [Breast cancer and hMG treatment: is there a relationship?].. PubMed. 24(7). 679–82. 1 indexed citations
6.
Favre, Gilles, et al.. (1993). Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie. 75(9). 811–819. 59 indexed citations
7.
Favre, Gilles, et al.. (1993). Importance of mevalonate‐derived products in the control of HMG‐CoA reductase activity and growth of human lung adenocarcinoma cell line a549. International Journal of Cancer. 55(4). 640–645. 67 indexed citations
8.
Favre, Gilles, et al.. (1993). High density lipoprotein3 binding sites are related to DNA biosynthesis in the adenocarcinoma cell line A549. Journal of Lipid Research. 34(7). 1093–1106. 12 indexed citations
9.
Perrin, D, et al.. (1983). [Cirrhogenous hepatitis due to suloctidil (Fluvisco)].. PubMed. 7(12). 1042–4. 3 indexed citations
10.
Audran, M, et al.. (1982). [Paraneoplastic hypercalcemia disclosing cholangiocarcinoma. Remission after hepatectomy].. PubMed. 6(12). 983–8. 2 indexed citations
11.
Périni, Jean‐Marc, Viviane Dumur, F Gaillard, & Michel Dautrevaux. (1982). Chemical deglycosylation assay by HF applied to human transcortin. Biochimie. 64(5). 381–383. 1 indexed citations
12.
Gaillard, F, et al.. (1981). [Reflux esophagitis: epidemiology, histology, and course in 123 cases (author's transl)].. PubMed. 5(3). 266–74. 3 indexed citations
13.
Degott, Claude, et al.. (1981). [Anatamo-pathologic aspects of gold-salt induced cholestasis. Report of two cases with ultrastructural study (author's transl)].. PubMed. 29(2). 547–104. 2 indexed citations
14.
Jacrot, B., et al.. (1980). Transcortin: A neutron scattering study of a glycoprotein. FEBS Letters. 122(2). 203–206. 4 indexed citations
15.
Gaillard, F, et al.. (1980). [Chronic idiopathic intestinal pseudo-obstruction. Pathophysiological study of a case. Review of the literature (author's transl)].. PubMed. 4(5). 338–47. 1 indexed citations
16.
Prost, A., et al.. (1978). [Fluorine osteosis caused by a very long-term niflumic acid treatment in 2 cases of rheumatoid arthritis].. PubMed. 45(12). 707–16. 2 indexed citations
17.
Jf, Chatal, et al.. (1977). [Radioimmunoassay of carcinoembryonic antigen in gastric carcinoma (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 1(5). 415–24. 1 indexed citations
18.
Racadot, André, et al.. (1976). Dosage de la transcortine serique par electro-immunodiffusion. Clinica Chimica Acta. 66(2). 171–180. 14 indexed citations
19.
Gaillard, F, Kia‐Ki Han, & Michel Dautrevaux. (1975). Caractérisation et propriétés physico-chimiques de la transcortine humaine. Biochimie. 57(5). 559–568. 39 indexed citations
20.
Gaillard, F, et al.. (1974). Isolement de la transcortine humaine par chromatographie d'affinité. Biochimie. 56(1). 99–108. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026